KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Progyny (PGNY) Gains from Investment Securities (2018 - 2025)

Progyny (PGNY) has disclosed Gains from Investment Securities for 8 consecutive years, with -$3.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities changed N/A to -$3.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$3.6 million, a N/A change, with the full-year FY2025 number at -$100000.0, up 92.86% from a year prior.
  • Gains from Investment Securities was -$3.9 million for Q4 2025 at Progyny, down from -$79000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $18.0 million in Q4 2021 to a low of -$5.5 million in Q3 2022.
  • A 5-year average of $1.6 million and a median of -$13000.0 in 2022 define the central range for Gains from Investment Securities.
  • Peak YoY movement for Gains from Investment Securities: plummeted 33153.85% in 2023, then soared 17075.0% in 2024.
  • Progyny's Gains from Investment Securities stood at $18.0 million in 2021, then tumbled by 100.07% to -$13000.0 in 2022, then tumbled by 33153.85% to -$4.3 million in 2023, then grew by 25.33% to -$3.2 million in 2024, then dropped by 19.55% to -$3.9 million in 2025.
  • Per Business Quant, the three most recent readings for PGNY's Gains from Investment Securities are -$3.9 million (Q4 2025), -$79000.0 (Q1 2025), and -$3.2 million (Q3 2024).